MONTREAL, Feb. 18, 2026 /PRNewswire/ - E-Biotech® today formally announced the launch of its patent-pending artificial intelligence infrastructure platform for pharmaceutical and GMP compliance, ...
Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of a ...
Artificial intelligence is transforming knowledge work across industries. Yet one of the most tightly regulated operational environments in the ...
“Partnering with Demeetra strengthens our ability to support biotech companies with a rapid and reliable path to GMP material ...
VANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA)(OTCQB:PMBHF), a Canadian biotechnology company dedicated to the research and ...
TORONTO, April 05, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and ...
In today’s fast-paced biopharmaceutical industry, accelerating microbial process development is critical for moving from gene to GMP with greater speed and efficiency. This webinar will highlight ...
Join us for this insightful, one-hour discussion with industry experts on navigating Good Manufacturing Practice (GMP) regulations in pharmaceutical storage. Discover how to plan ahead and find the ...
The MarketWatch News Department was not involved in the creation of this content. MONTREAL, Feb. 18, 2026 /CNW/ - E-Biotech(R) today formally announced the launch of its patent-pending artificial ...
Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results